Evidence map›Paper›PMID 24717351›Full record

ArticleJournal of neurophysiology2014

Selective modulation of GABAergic tonic current by dopamine in the nucleus accumbens of alcohol-dependent rats.

Jing Liang, Vincent N Marty, Yatendra Mulpuri, Richard W Olsen, Igor Spigelman

Open access · greenAbstract read
In one paragraph

Article in Journal of neurophysiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Modulation of neuronal excitability by binge alcohol drinking.Frontiers in molecular neuroscience · 2023
    Review
  2. Specific Plasticity Loci and Their Synergism Mediate Operant Conditioning.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Suppression of GABAergic neurons through D2-like receptor secures efficient conditioning inProceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  7. Article
  8. Dopaminergic control of anxiety in young and aged zebrafish.Pharmacology, biochemistry, and behavior · 2017
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jing LiangDivision of Oral Biology and Medicine, School of Dentistry, University of California, Los Angeles, California; and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California.
Vincent N MartyDivision of Oral Biology and Medicine, School of Dentistry, University of California, Los Angeles, California; and.
Yatendra MulpuriDivision of Oral Biology and Medicine, School of Dentistry, University of California, Los Angeles, California; and.
Richard W OlsenDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California.
Igor SpigelmanDivision of Oral Biology and Medicine, School of Dentistry, University of California, Los Angeles, California; and igor@ucla.edu.
University of California, Los Angeles · US

Funding

GABA RECEPTOR COMPLEX IN ALCOHOL DEPENCENCER37AA007680 · NIAAA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI OLSEN, RICHARD W · 1998 to 2006
$1.8M
GABA RECEPTOR COMPLEX IN ALCOHOL DEPENDENCER01AA007680 · NIAAA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI OLSEN, RICHARD W · 1988 to 2012
$1.8M
Mechanisms of GABAA Receptor Plasticity in AlcoholismR01AA016100 · NIAAA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SPIGELMAN, IGOR · 2007 to 2011
$1.7M
Mechanisms underlying effects of Hovenia-dihydromyricetin on alcohol intoxicationR21AA017991 · NIAAA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LIANG, JING · 2009 to 2010
$415k
NIAAA NIH HHS AA-016100NIAAA NIH HHS AA-017991NIAAA NIH HHS AA-07680
6 · The paper itself

Abstract

The nucleus accumbens (NAcc) is a key structure of the mesolimbic dopaminergic reward system and plays an important role in mediating alcohol-seeking behaviors. Alterations in glutamatergic and GABAergic signaling were recently demonstrated in the NAcc of rats after chronic intermittent ethanol (CIE) treatment, a model of alcohol dependence. Here we studied dopamine (DA) modulation of GABAergic signaling and how this modulation might be altered by CIE treatment. We show that the tonic current (I(tonic)) mediated by extrasynaptic γ-aminobutyric acid type A receptors (GABA(A)Rs) of medium spiny neurons (MSNs) in the NAcc core is differentially modulated by DA at concentrations in the range of those measured in vivo (0.01-1 μM), without affecting the postsynaptic kinetics of miniature inhibitory postsynaptic currents (mIPSCs). Use of selective D1 receptor (D1R) and D2 receptor (D2R) ligands revealed that I(tonic) potentiation by DA (10 nM) is mediated by D1Rs while I(tonic) depression by DA (0.03-1 μM) is mediated by D2Rs in the same MSNs. Addition of guanosine 5'-O-(2-thiodiphosphate) (GDPβS) to the recording pipettes eliminated I(tonic) decrease by the selective D2R agonist quinpirole (5 nM), leaving intact the quinpirole effect on mIPSC frequency. Recordings from CIE and vehicle control (CIV) MSNs during application of D1R agonist (SKF 38393, 100 nM) or D2R agonist (quinpirole, 2 nM) revealed that SKF 38393 potentiated I(tonic) to the same extent, while quinpirole reduced I(tonic) to a similar extent, in both groups of rats. Our data suggest that the selective modulatory effects of DA on I(tonic) are unaltered by CIE treatment and withdrawal.

Indexed as

Inhibitory Postsynaptic PotentialsMiniature Postsynaptic Potentials2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineAlcoholismAnimalsDopamineDopamine AgonistsGuanosine DiphosphateMaleNeuronsNucleus AccumbensQuinpiroleRatsRats, Sprague-DawleyReceptors, Dopamine D1Receptors, Dopamine D22,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineDopamineDopamine Agonistsguanosine 5'-O-(2-thiodiphosphate)Guanosine DiphosphateQuinpiroleReceptors, Dopamine D1Receptors, Dopamine D2Receptors, GABA-AThionucleotidesethanolneuroadaptationtonic currentventral striatumwithdrawal

Identifiers

PMID24717351
PMCPMC4064388
OpenAlexW2112362543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.